Abstract | OBJECTIVE: METHODS: DBA/1 mice were immunized with CII to induce arthritis and were subsequently treated with CTB-CII, CTB-conjugated ovalbumin, or CII alone. The incidence and severity of arthritis were assessed clinically and histologically. RESULTS: Treatment with CTB-CII conjugate effectively suppressed leukocyte infiltration into the synovium and prevented bone erosion. Comparable doses of unconjugated CII administered by the same route were relatively ineffective. Protection with nasal CTB-CII vaccine was associated with decreased production of interleukin-4 (IL-4), IL-6, and interferon-gamma and with reduced CII-specific IgG1 and IgG2a antibody responses in regional lymph nodes. CONCLUSION: Nasal treatment with CTB-CII appears to result in decreased peripheral Th1 and Th2 responses to collagen. These results suggest that intranasal vaccination with CTB-CII may offer an effective immunotherapeutic means for the control of chronic polyarthritis.
|
Authors | A Tarkowski, J B Sun, R Holmdahl, J Holmgren, C Czerkinsky |
Journal | Arthritis and rheumatism
(Arthritis Rheum)
Vol. 42
Issue 8
Pg. 1628-34
(Aug 1999)
ISSN: 0004-3591 [Print] United States |
PMID | 10446861
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Autoantibodies
- Immunotoxins
- Vaccines
- Collagen
- Cholera Toxin
|
Topics |
- Administration, Intranasal
- Animals
- Antibody Formation
(immunology)
- Arthritis, Experimental
(immunology, prevention & control)
- Autoantibodies
(immunology)
- Autoimmune Diseases
(prevention & control)
- Cholera Toxin
(immunology)
- Collagen
(immunology)
- Disease Progression
- Immunotoxins
(immunology)
- Male
- Mice
- Mice, Inbred DBA
- Vaccines
(administration & dosage)
|